NDC properties for NDC 9 0591-3217
NDC item 00591321726
NDC 9 | 0591-3217 |
---|---|
NDC 10 | 0591-3217-26 |
NDC Item | 00591321726 |
packaging | 5 g in 1 PACKET |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-04 |
Marketing status | ACTIVE |
NDC item 00591321730
NDC 9 | 0591-3217 |
---|---|
NDC 10 | 0591-3217-30 |
NDC Item | 00591321730 |
packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-04 |
Marketing status | ACTIVE |
NDC item 00591352426
NDC 9 | 0591-3524 |
---|---|
NDC 10 | 0591-3524-26 |
NDC Item | 00591352426 |
packaging | 5 g in 1 TUBE |
ANDA | ANDA091073 |
DCSA | CIII |
FDA SPL set id | 738425 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2017-10-12 |
Marketing status | ACTIVE |
NDC item 00591352430
NDC 9 | 0591-3524 |
---|---|
NDC 10 | 0591-3524-30 |
NDC Item | 00591352430 |
packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
ANDA | ANDA091073 |
DCSA | CIII |
FDA SPL set id | 738425 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2017-10-12 |
Marketing status | ACTIVE |
NDC item 00832112005
NDC 9 | 0832-1120 |
---|---|
NDC 10 | 0832-1120-05 |
NDC Item | 00832112005 |
packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
NDC item 00832112035
NDC 9 | 0832-1120 |
---|---|
NDC 10 | 0832-1120-35 |
NDC Item | 00832112035 |
packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
NDC item 00832112065
NDC 9 | 0832-1120 |
---|---|
NDC 10 | 0832-1120-65 |
NDC Item | 00832112065 |
packaging | 5 g in 1 TUBE |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
NDC item 00832112089
NDC 9 | 0832-1120 |
---|---|
NDC 10 | 0832-1120-89 |
NDC Item | 00832112089 |
packaging | 5 g in 1 PACKET |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
NDC item 21922001902
NDC 9 | 21922-019 |
---|---|
NDC 10 | 21922-019-02 |
NDC Item | 21922001902 |
packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
ANDA | ANDA212984 |
DCSA | CIII |
FDA SPL set id | 770936 |
Labeler | Encube Ethicals Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
NDC item 49884051063
NDC 9 | 49884-510 |
---|---|
NDC 10 | 49884-510-63 |
NDC Item | 49884051063 |
packaging | 5 g in 1 PACKET |
ANDA | ANDA076744 |
DCSA | CIII |
FDA SPL set id | 660010 |
Labeler | Endo USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-09-02 |
Marketing status | COMPLETED |
NDC item 49884051072
NDC 9 | 49884-510 |
---|---|
NDC 10 | 49884-510-72 |
NDC Item | 49884051072 |
packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
ANDA | ANDA076744 |
DCSA | CIII |
FDA SPL set id | 660010 |
Labeler | Endo USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-09-02 |
Marketing status | COMPLETED |
NDC item 63629212501
NDC 9 | 63629-2125 |
---|---|
NDC 10 | 63629-2125-1 |
NDC Item | 63629212501 |
packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
ANDA | ANDA076744 |
DCSA | CIII |
FDA SPL set id | 762728 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-09-02 |
Marketing status | ACTIVE |
NDC item 63629958501
NDC 9 | 63629-9585 |
---|---|
NDC 10 | 63629-9585-1 |
NDC Item | 63629958501 |
packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
ANDA | ANDA212984 |
DCSA | CIII |
FDA SPL set id | 785842 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-19 |
Marketing status | COMPLETED |
NDC item 64380015201
NDC 9 | 64380-152 |
---|---|
NDC 10 | 64380-152-01 |
NDC Item | 64380015201 |
packaging | 5 g in 1 DOSE PACK |
ANDA | ANDA076744 |
COLORTEXT | WHITE(clear, colorless) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 793741 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-06-27 |
Marketing status | ACTIVE |
NDC item 64380015202
NDC 9 | 64380-152 |
---|---|
NDC 10 | 64380-152-02 |
NDC Item | 64380015202 |
packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
ANDA | ANDA076744 |
COLORTEXT | WHITE(clear, colorless) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 793741 |
Labeler | Strides Pharma Science Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-06-27 |
Marketing status | ACTIVE |
NDC item 66993093430
NDC 9 | 66993-934 |
---|---|
NDC 10 | 66993-934-30 |
NDC Item | 66993093430 |
packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
DCSA | CIII |
FDA SPL set id | 304583 |
Labeler | Prasco Laboratories |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time high | 2019-02-12 |
Marketing effective time low | 2014-06-09 |
Marketing status | COMPLETED |
NDA_AUTHORIZED_GENERIC | NDA021454 |
NDC item 66993093454
NDC 9 | 66993-934 |
---|---|
NDC 10 | 66993-934-54 |
NDC Item | 66993093454 |
DCSA | CIII |
FDA SPL set id | 304583 |
Labeler | Prasco Laboratories |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time high | 2019-02-12 |
Marketing effective time low | 2014-06-09 |
Marketing status | COMPLETED |
NDA_AUTHORIZED_GENERIC | NDA021454 |